Choi C et al. |
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma. |
2016 |
J. Clin. Oncol. |
pmid:28248126
|
Burr SP et al. |
Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions. |
2016 |
Cell Metab. |
pmid:27923773
|
Tyrakis PA et al. |
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. |
2016 |
Nature |
pmid:27798602
|
Nadtochiy SM et al. |
Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling. |
2016 |
J. Biol. Chem. |
pmid:27510037
|
Flavahan WA et al. |
Insulator dysfunction and oncogene activation in IDH mutant gliomas. |
2016 |
Nature |
pmid:26700815
|
de la Fuente MI et al. |
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. |
2016 |
Neuro-oncology |
pmid:26691210
|
Emir UE et al. |
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations. |
2016 |
Cancer Res. |
pmid:26669865
|
Liesenfeld DB et al. |
Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial. |
2016 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:26585118
|
Andronesi OC et al. |
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. |
2016 |
Clin. Cancer Res. |
pmid:26534967
|
Waitkus MS et al. |
Isocitrate dehydrogenase mutations in gliomas. |
2016 |
Neuro-oncology |
pmid:26188014
|